C. Frederick Hollon
Research |
| 2005-Current |
Sub-investigator: To evaluate the safety and efficacy of toremifene in preventing prostate cancer in high risk men with high grade intraepithelial neoplasia. PIN G300104. |
| 2004-Current |
Sub-investigator: A randomized, double-blind, placebo-controlled, multi-center efficacy and safety study of toremifene citrate for the prevention of bone fractures in men with prostate cancer on androgen deprivation therapy. G300203 GTx, Inc. TOPCAT. |
| 2004-2005 |
Sub-investigator: Study of duloxetine HCL in women of different demographic characteristics and co-mobidities with stress urinary incontinence: evaluation of efficacy and safety. DESIRE F1J-US-SBCD. |
| 2003-Current |
Sub-investigator: A randomized, double-blind, parallel group study to investigate the efficacy and safety of treatment with dutasteride (0.5mg) and Tarsulosin (0.4mg), administered once daily for four years, alone and in combination, on the improvement of symptoms and clinical outcomes in men with moderate to severe symptomatic benign prostatic hyperplasia. AR 140005 combAt. |
